General Biologicals Corporation (TPEX:4117)

General Biologicals Revenue

General Biologicals had revenue of 110.73M TWD in the half year ending June 30, 2025, a decrease of -17.18%. This brings the company's revenue in the last twelve months to 251.38M, up 3.70% year-over-year. In the year 2024, General Biologicals had annual revenue of 251.93M, down -4.87%.

• Revenue (ttm): 251.38M
• Revenue Growth: +3.70%
• P/S Ratio: 2.94
• Revenue / Employee: 3.10M
• Employees: 81
• Market Cap: 739.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	251.93M	-12.90M	-4.87%
Dec 31, 2023	264.83M	-105.63M	-28.51%
Dec 31, 2022	370.46M	-181.20M	-32.85%
Dec 31, 2021	551.66M	75.79M	15.93%
Dec 31, 2020	475.87M	236.22M	98.57%